FibroBiologics Secures $100 Million to Support Cell Therapy
Funds will support development of a fibroblast-based cell therapy platform with application in orthopedics and disc degeneration....
Funds will support development of a fibroblast-based cell therapy platform with application in orthopedics and disc degeneration....
HAPPE's orthopedic material platform transforms PEEK into a hydrophilic, bioactive, osteointegrating material....
We recap 18 funding announcements that took place since June 2021. Many of the companies are familiar names with previously-closed...
Three companies – Treace Medical Concepts, Bioventus and Paragon 28 – made the leap in 2021. Market conditions could induce...
Paragon 28 is focused on orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments....
Funds will support development of its next generation surgical robot for orthopedics. Its first application is for knee replacement....
Bone Biologics is currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion....
The company's SmartFuse technology platform was designed to remotely stimulate, control and monitor bone growth....
The 50-patient study will support an application for clearance of anterior cervical plates and interbody cages for commercial use....
The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.